Press Releases

Fighting every day to free individuals — and the families who love them — from the harmful effects of muscle-debilitating diseases so they can live longer and grow stronger

Press Releases

  • MDA Telethon Ends Historic Run, Urgent Fight for Families Continues

    CHICAGO, May 1, 2015 — MDA, the Muscular Dystrophy Association, today announced that the new realities of television viewing and philanthropic giving have made this the right time for the organization to move beyond its historic Labor Day telethon. It will discontinue production of a broadcast telethon effective this year.

  • Kroger-Atlanta Division Raises More Than $292,000 Through MDA Shamrock Program To Help People Fighting Muscle Disease

    ATLANTA, April 8, 2015 — More than 186 Kroger-Atlanta Division stores in Georgia, South Carolina and Eastern Alabama teamed with customers to raise more than $292,000 to help save and improve the lives of people fighting muscle disease during the 33rd annual MDA Shamrock program to benefit the Muscular Dystrophy Association.

  • Tempaper and MDA Team Up in the Fight Against Muscle Disease

    Virtual giving campaign encourages people to change their space and help change the lives of those living with muscle disease


    Virtual giving campaign encourages people to change their space and help change the lives of those living with muscle disease

  • MDA 2015 Scientific Conference to Emphasize Urgent Need for Discovery and Treatment

    Leading experts in neuromuscular disease research and drug development will present and exchange ideas and information March 11-14

  • MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease

    – Small Steps Fund Powerful Progress –


    CHICAGO, Feb.  27, 2015 — Thousands of people in local communities nationwide will take a small step to fund powerful progress for the Muscular Dystrophy Association during the 2015 MDA Muscle Walk season by raising critical funds and awareness that will help save and improve the lives of children and adults fighting muscle disease.

  • ReveraGen BioPharma Announces Start of Phase 1 Clinical Trial of VBP15 Dissociative Steroid Drug

    Product holds potential for replacing glucocorticoids in Duchenne muscular dystrophy and other chronic inflammatory states

    SILVER SPRING, M.D./ CHICAGO – February 18, 2015 – ReveraGen BioPharma today announced the start of a Phase 1, first-in-human, clinical trial of a novel dissociative steroidal drug, VBP15, under development for Duchenne muscular dystrophy.  Recruitment in the trial is underway, with the initial doses in the first volunteers having been received.